In a menopausal woman using cyclic progesterone therapy (2 weeks on, 2 weeks off), how frequently should a withdrawal bleed occur?

Expected Bleeding Frequency with Cyclic Progesterone (2 weeks on, 2 weeks off)

With cyclic progesterone therapy administered for 2 weeks on and 2 weeks off in menopausal women, you should expect withdrawal bleeding to occur once per month (approximately every 28 days), typically starting within a few days after stopping the progesterone phase.

Bleeding Pattern Details

The standard cyclic regimen produces predictable monthly withdrawal bleeding in the vast majority of women:

• Timing of onset: Bleeding typically begins around day 13 after starting progesterone (or within 2-7 days after stopping the 2-week progesterone course) 1
• Expected frequency: Approximately monthly (once per 28-day cycle) 2, 1
• Success rate: Studies show that cyclic administration of progestogen for 10-14 days produces regular withdrawal bleeding in 73-100% of women 3, 4, 5

Clinical Evidence

The FDA-approved progesterone labeling demonstrates that when progesterone capsules 200 mg are given for 12 days per 28-day cycle with continuous estrogen, this regimen produces monthly menstrual periods 3. In premenopausal women with secondary amenorrhea, 10 days of progesterone therapy resulted in 73.8-80% of women experiencing withdrawal bleeding 3.

Multiple guidelines confirm this pattern. The 2021 Blood Reviews guidelines specify that sequential regimens with estrogen administered continuously and progestogen for 12-14 days every 28 days result in withdrawal bleeding once monthly 6. The 2011 AACE guidelines state that "cyclic administration of the progestagen usually produces monthly menstrual periods" 1.

Important Clinical Considerations

Bleeding timing does NOT predict endometrial safety: A critical caveat is that the timing of withdrawal bleeding onset (early vs. late in the cycle) does not correlate with endometrial histology and should not be used as reassurance of normal endometrium 7. Even with appropriate progesterone dosing for 10-12 days, approximately 2.4-2.8% of women may still develop endometrial hyperplasia 7.

Individual variation exists: While most women bleed predictably, research shows that in sequential regimens:

• Regular withdrawal bleeding occurs in 77-81% of cycles 4
• Amenorrhea may occur in approximately 5% of women 4
• Irregular bleeding or spotting accounts for 8-10% of cycles 5

Progestogen type matters: The specific progestogen used affects bleeding patterns. Studies comparing different progestogens in sequential regimens found that nomegestrol acetate and dydrogesterone produced more regular withdrawal bleeding (higher rates of predictable monthly bleeding) compared to micronized progesterone, which had more irregular bleeding episodes 5.

Clinical Algorithm

For a menopausal woman on cyclic progesterone (2 weeks on, 2 weeks off):

1. Expected pattern: Anticipate withdrawal bleeding once monthly, starting 2-7 days after completing the progesterone phase
2. If amenorrhea occurs: This happens in ~5% of women and may be acceptable if endometrial monitoring is normal
3. If irregular bleeding occurs: Requires endometrial evaluation regardless of cycle timing, as bleeding patterns do not predict hyperplasia 7
4. If continuous bleeding desired: Consider switching to continuous combined regimens, which produce amenorrhea in 61-73% of women after several months 4

The 2-week on, 2-week off regimen is essentially equivalent to the standard 12-14 days per month dosing studied in clinical trials, and should produce the same monthly withdrawal bleeding pattern.